Immunogenicity and Safety of CYD Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines.
Phase of Trial: Phase II
Latest Information Update: 08 May 2015
At a glance
- Drugs CYD TDV (Primary) ; Hepatitis A vaccine inactivated; Measles mumps and rubella virus vaccine; Varicella zoster virus vaccine live
- Indications Chickenpox; Dengue; Hepatitis A
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Sanofi
- 08 Oct 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 19 Feb 2010 New trial record